Über Articles - how to get totally unique FREE content for your website

Display Category\|Title\|Newest\|Oldest
What can we do about pain? The articles notes that, in the centuries before modern science produced pain killers, people managed pain through a variety of techniques. While accepting that sometimes pain levels do demand chemical solutions, it argues that we should not be too quick to resort to pills for long-term pain management. Warm hands can make for a healthy heart The article looks at the extremes of just relying on medication as against "expensive" therapy time, and decides that biofeedback may be a middle ground for the treatment of insomnia. Lose the weights for weight loss The articles combines news from the most recent clinical trial of acomplia with advice on how best to exercise to produce optimum health outcomes. The die is cast (not machined) The article proves the point that the first step in any cure is taking the decision that you want your life to go on. If you give up, you die. Thinking about going back to work, is making a commitment to life. Good news from Istanbul This article considers the results of the ADAGIO-LIPIDS study presented at Istanbul and concludes that it provides more encouraging evidence that, used wisely, acomplia is a highly effective treatment for those who are overweight and at risk of cardiovascular disease. Instead of counting sheep, we should be counting prescriptions The article wonders why insomnia seems to have become an epidemic. Millions of prescriptions a day are written around the world. Perhaps it is the 24/7 lifestyle or that we worry too much. Whatever it is, the world as a whole is suffering from lack of sleep. Prejudice and disability The article reflects on the nature of disability and considers why many for suffer from anxiety and panic attacks fail to complete the course of treatment Friday The article identifies the problems that any family can experience when one member is planning to start taking a potentially addictive medication that also has recreational use and a street value. Monday The article captures the sense of nervous anticipation a person would feel the very first time she is to take a powerful medication. She is not sure how it will affect her, how she will feel afterwards. The United States is starting to take weight loss more seriously The article contrasts the success of the more scientific test of diet among school children in Philadelphia with the problems adults have in keeping their motivation to lose weight. Tuesday The article makes the point that even though a medication like Ambien can give you one or two nights of good sleep, you have to relearn how to sleep at the same time every night. This means that you cannot sleep during the day. Kicking my heels The article considers the real level of effectiveness of a medication like Acomplia. It concludes that Acomplia can do no more than offer support. The human being is always responsible for actually eating less and continuing the decision not to smoke. Not just a weight on my mind The article makes two points about the recovery cycle after a heart attack. The patient has first to accept the need to start exercise as soon as possible to restore some muscle tone. And the patient has to stop feeling sorry for himself. Learning from the past The article looks back to 1994 when the cost of anxiety disorders to the US economy was $65 billion. Because public health care is underfunded, treatments have focused on oral medications as the cheap solution rather than expensive behavioural therapy which has a better chance of a cure. Thanks to Ambien The article introduces a forty something housewife who is keeping a diary about her first experiences with Ambien. She is to be paid in kind to write about her life. She is not being paid to endorse Ambien, but for an honest report of her reaction to the medication. Wednesday The article considers one of the problems with clinical trials for new medications. The fact that there is a scientifically documented phenomenon called the “placebo effect” means people can distort the research findings. Unfortunately, getting a naive participant to give unbiased finding is unethical. Facts and speculations about weight gain The aricle looks at the relaionship between zoloft and weight gain. It initially prefers the explanation that any weight gain is due to overeating, but then accepts the possibility that some people will experience weight gain as a side effect to themedication. What will the world be like when the sleeper awakes in 2018? The article looks at a new marketing report for the sleep disorder market which predicts continuing strong growth for both existing and new medications. Those black box warnings on antidepressants The article asserts that the black box warnings on the risk of suicide sent out with zoloft do not properly answer the question, "What is the precise role of zoloft?" Until they do, people cannot make an informed decision on whether to use the medication. History of Acomplia during 2007 The article reviews the history of acomplia during 2007, showing how new countries began subsidising the medication out of public funds, and reviewing the steps taken by the EU to increase the level of its warning of psychiatric side effects. Those online pharmacies! The article repeats the news that a US physician was convicted of suppling prescriptions to an online pharmacy without ensuring a good medical reason. But confirms that, when the prices of many household necessities are rising, it is entirely rational to buy medications at discounted prices online. So you can not sleep? So what? The article considers evidence from both the UK and the USA showing that insomnia is increasingly prevalent and that the costs associated with it are reasonably significant. In the face of this evidence, it argues that society should be prepared to pick up the cost of research into the cause and better treatment methods. Should DUI become DUIA? The articles notes a paper presented in the March meeting of the American Academy of Forensic Science which identified ambien as one of the top ten drugs found in blood samples following arrests for traffic offences. It seems that "sleep driving" may be a new danger to other road users. Keeping both the mind and the body healthy The article examines the latest research evidence that physical exercise improves mood. Those taking acomplia are always advised to exercise on a regular basis. This could help to offset some of the psychological side effects sometimes associated with acomplia. What is the story behind pre-emption? The article visits the thorny legal question of pre-emption in relation to the liability of drug companies. It concludes that the Supreme Court should allow people injured by medications to sue. How do you stay at the top of your league? The article notes that the Neurogen Corp., a biotech company based in Connecticut, has just laid off forty-five staff and raised $30m so that it can afford to pay for the trials to prove the worth of a competitor to Ambien (and three other medications). Is the gamble worth the jobs of forty-five employees? What can be done about depression in Alzheimer's Disease? The article considers whether there is any evidence that Zoloft may assist people who have Alzheimer’s Disease and are depressed. It concludes that the limited evidence is quite encouraging. Treatment of shyness The article considers how many people now turn to Xanax for the treatment of shyness. It is perhaps an unfortunate symptom of a shortage of doctors and the money to pay them to deal with psychological problems through counselling and therapy. Medication is cheaper and quicker and very short term. The Mayo Clinic on weight The article looks at two new pieces of research which show the United States facing a major health crisis from obesity. It points to a new strategy for tackling the problem but, given the time taken to bring new medications to the market, regrets the FDA’s reluctance to approve new medications such as Acomplia. Daniel Smith’s death was accidentally fatal The article reflects on the news of the inquest verdict on the death of Daniel Smith. Although the way he died could be an accident, it may also be as a result of the suicide risks in the use of Selective Serotonin Reuptake Inhibitors. Yet perhaps it is always better not to characterise a death as suicide unless it is unavoidable. Top performing medication for losing weight. This article examines the meta-research analysis published in the British Medical Journal in which Acomplia proved to be the weight loss medication with the best results for weight loss and for those participants diagnosed with diabetes. Thin-film way to better sleep The article looks at the development of a new delivery system for Ambien. A US-based company is applying thin-film technology to deliver the medication in a convenient new form as a lozenge. Placed on the tongue, it dissolves rapidly. Weight loss market today The article looks that three pieces of news: that the market for antiobesity medications is going to grow by a factor of five, that Acomplia may prevent liver disease and that the German courts have confirmed their decision not to allow the subsidy of Acomplia out of public funds. It is shame that a medication that is no needed cannot gain regulatory approval for its full range of effect. What can help you to battle the jet lag? The article registers mild surprise that Ambien has now become the drug of choice for the Red Sox as they battle the jet lag to play their opening baseball games in Japan. It seems that Ambien is the fastest way to reset the circadian rhythms to local time. By 2020 depression can be second top cause of death in US. The article questions whether the use of medications such as Zoloft is justified since no-one dies of being depressed. After examining the evidence for the incidence of psychiatric illnesses and its effects, it concludes that morally and economically, states should treat depression as a high priority in the provision of health cover. Balancing of the benefits of anxiety relief against the risk of the prescription drug abuse The article looks at the problem of reconciling patient safety against public safety. People need access to safe medications like Xanax. The fact that several million people around the word may be abusing prescription medications, cannot be allowed to distract from the benefits to millions more individual patients who use the medications properly. Why does anxiety increase the risk of a heart attack? The article reports on the research findings that the blood coagulation process of those who suffer from anxiety or panic disorders is unbalanced. This may expose such people to a higher risk of a stroke or heart attack. Coping with social anxiety disorder under the camera's eye. The article is an obituary for Heath Ledger, the Australian movie actor who died in January 2008. It reflects on the fact that he relied on Xanax to remain functional in the face of intrusive media pressure. Sadly, he took a cocktail of medications and died.

RSS Subscribe: